Clinical Trial Update: An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

An extension study for treatment of moderately to severely active ulcerative colitis in Phase 3 is ongoing (ACTIVE_NOT_RECRUITING).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Pfizer | Conditions: Ulcerative Colitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING